EUVIMEDEUVIMED entdecken
Open Access

Increased White Matter Aerobic Glycolysis in Multiple Sclerosis

Matthew R Brier iD, Bradley Judge, Chunwei Ying, Amber Salter iD, Hongyu An, Aakash Patel, Qing Wang, Yong Wang, Anne H Cross iD, Robert T Naismith, Tammie Ls Benzinger, Manu S Goyal

Annals of Neurology · 2025

DOI: 10.1002/ana.27165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, 2025. Verfasst von Matthew R Brier und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Washington University School of Medicine, St. Louis, MO. Hauptthemen laut MEDLINE: Glycolysis, White Matter, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Center for Advancing Translational Sciences (NCATS), NINDS NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Despite treatments which reduce relapses in multiple sclerosis (MS), many patients continue to experience progressive disability accumulation. MS is associated with metabolic disruptions and cerebral metabolic stress predisposes to tissue injury and possibly impaired remyelination. Additionally, myelin homeostasis is metabolically expensive and reliant on glycolysis. We investigated cerebral metabolic changes in MS and when in the disease course they occurred, and assessed their relationship with microstructural changes.

Methods

This study used combined fluorodeoxyglucose (FDG) positron emission tomography (PET) and magnetic resonance imaging (MRI) to measure cerebral metabolic rate of glucose and oxygen, thereby quantifying glycolysis. Twelve healthy controls, 20 patients with relapsing MS, and 13 patients with non‐relapsing MS were studied. Relapsing patients with MS were treatment naïve and scanned pre‐ and post‐initiation of high efficacy disease modifying therapy.

Results

In normal appearing white matter, we observed increased glucose utilization and reduced oxygen utilization in newly diagnosed MS, consistent with increased glycolysis. Increased glycolysis was greater in patients with a longer disease duration course and higher disability. Among newly diagnosed patients, different treatments had differential impacts on glucose utilization. Last, whereas hypermetabolism within lesions was clearly associated with inflammation, no such relationship was found within normal appearing white matter.

Interpretation

Increased white matter glycolysis is a prominent feature of cerebral metabolism in MS. It begins early in the disease course, increases with disease duration and is independent of microstructural evidence of inflammation in normal appearing white matter. Optimization of the metabolic environment may be an important component of therapies designed to reduce progressive disability. ANN NEUROL 2025;97:766–778

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycolysisWhite MatterMultiple SclerosisMultiple Sclerosis, Relapsing-RemittingHumansFemaleMaleAdultMiddle AgedPositron-Emission TomographyMagnetic Resonance ImagingFluorodeoxyglucose F18Glucose

Substanzen

Fluorodeoxyglucose F18Glucose

Autor:innen und Institutionen

  • Department of Neurology, Washington University School of Medicine, St. Louis, MO.
  • Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO.
  • Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX.
  • Department of Psychiatry, Washington University School of Medicine, St. Louis, MO.
  • Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO.

ORCID-Profile: Matthew R Brier, Amber Salter, Anne H Cross

Förderung

  • National Center for Advancing Translational Sciences (NCATS)
  • NINDS NIH HHS
  • NIA NIH HHS
  • NCATS NIH HHS
  • NIMH NIH HHS
  • National Multiple Sclerosis Society
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Brier, M. R., Judge, B., Ying, C., Salter, A., An, H., Patel, A., Wang, Q., Wang, Y., Cross, A. H., Naismith, R. T., Benzinger, T. L., & Goyal, M. S. (2025). Increased White Matter Aerobic Glycolysis in Multiple Sclerosis. Annals of Neurology. https://doi.org/10.1002/ana.27165

Vancouver

Brier MR, Judge B, Ying C, Salter A, An H, Patel A, et al. Increased White Matter Aerobic Glycolysis in Multiple Sclerosis. Annals of Neurology. 2025. doi:10.1002/ana.27165

BibTeX
@article{Brier2025,
  author = {Brier, Matthew R and Judge, Bradley and Ying, Chunwei and Salter, Amber and An, Hongyu and Patel, Aakash and Wang, Qing and Wang, Yong and Cross, Anne H and Naismith, Robert T and Benzinger, Tammie Ls and Goyal, Manu S},
  title = {Increased White Matter Aerobic Glycolysis in Multiple Sclerosis},
  journal = {Annals of Neurology},
  year = {2025},
  doi = {10.1002/ana.27165}
}
Kostenlos starten →